Tang Capital Management LLC Cytom X Therapeutics, Inc. Transaction History

Tang Capital Management LLC

$1.54 Billion
Q1 2025

A detailed history of Tang Capital Management LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 6,717,825 shares of CTMX stock, worth $15.5 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

6,717,825

Previous 7,311,760 8.12%

Holding current value

$15.5 Million

Previous $7.53 Million 42.92%

% of portfolio

0.28%

Previous 0.57%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.58 - $1.14 $344,482 - $677,085	-593,935 Reduced 8.12%	6,717,825 $4.3 Million
Q4 2024 Feb 14, 2025	SELL	$0.86 - $1.29 $430,000 - $645,000	-500,000 Reduced 6.4%	7,311,760 $7.53 Million
Q3 2024 Nov 14, 2024	BUY	$1.12 - $1.51 $22,202 - $29,934	19,824 Added 0.25%	7,811,760 $9.22 Million
Q2 2024 Aug 14, 2024	BUY	$1.21 - $5.13 $1.62 Million - $6.88 Million	1,341,936 Added 20.81%	7,791,936 $9.51 Million
Q1 2024 May 15, 2024	SELL	$1.41 - $2.74 $141,000 - $274,000	-100,000 Reduced 1.53%	6,450,000 $14.1 Million
Q4 2023 Feb 14, 2024	SELL	$1.07 - $1.55 $53,500 - $77,500	-50,000 Reduced 0.76%	6,550,000 $10.2 Million
Q2 2023 Aug 14, 2023	BUY	$1.41 - $1.92 $714,824 - $973,378	506,968 Added 8.32%	6,600,000 $11.4 Million
Q1 2023 May 15, 2023	BUY	$1.48 - $2.88 $3.82 Million - $7.44 Million	2,582,587 Added 73.57%	6,093,032 $9.2 Million
Q4 2022 Feb 14, 2023	BUY	$1.19 - $1.91 $2.92 Million - $4.69 Million	2,455,772 Added 232.85%	3,510,445 $5.62 Million
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $1.61 Million - $3.05 Million	1,054,673 New	1,054,673 $1.93 Million
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $406,761 - $712,974	-152,345 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.87 - $7.39 $589,575 - $1.13 Million	152,345 New	152,345 $660,000
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $730,333 - $891,752	-112,880 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $1.23 Million - $1.65 Million	-187,120 Reduced 62.37%	112,880 $751,000
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $1.08 Million - $2.58 Million	300,000 New	300,000 $2.3 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

44.9M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $152M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Account

Tang Capital Management LLC Cytom X Therapeutics, Inc. Transaction History